In 2009, we obtained a verdict from a Pennsylvania jury against Pfizer for $34 million for failing to warn patients of cancer risks associated with the hormone replacement drugs Premarin, Provera and Prempro.
In 2011, we obtained a verdict from a Pennsylvania jury that ordered Pfizer Inc. to pay $72.6 million in damages to three women represented by the firm, after three weeks of testimony regarding the link between breast cancer and menopause drugs.